Ablation of atrial tachycardia and atrial flutter in heart failure

Heart Failure Clinics

Volumn 9, Issue 4, 2013, Pages 501-514

  Bamimore, Ayotunde ^a   Mounsey, Paul ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Ablation; Atrial flutter; Atrial tachycardia; Heart failure; Tachyarrhythmia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOFETILIDE; DRONEDARONE; SOTALOL;

ALGORITHM; ANESTHESIA; CARDIOVASCULAR CATHETER; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CONSERVATIVE TREATMENT; DRUG CONTRAINDICATION; ELECTROCARDIOGRAM; ELECTRODE; ENDOCARDIUM; EPICARDIUM; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART FAILURE; HEART INFARCTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LUNG EDEMA; MORBIDITY; PREVALENCE; REVIEW; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA INDUCED CARDIOMYOPATHY; TREATMENT OUTCOME; TREATMENT PLANNING;

ABLATION; ATRIAL FLUTTER; ATRIAL TACHYCARDIA; HEART FAILURE; TACHYARRHYTHMIA;

ATRIAL FLUTTER; CATHETER ABLATION; HEART CONDUCTION SYSTEM; HEART FAILURE; HUMANS; TACHYCARDIA, ECTOPIC ATRIAL;

EID: 84884414247     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.07.002     Document Type: Review

References (52)

1. Markides V., Peters N.S. Mechanisms underlying the development of atrial arrhythmias in heart failure. Heart Fail Rev 2002, 7:243-253.
2. Saoudi N., Cosio F., Waldo A., et al. Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol 2001, 12:852-866.
3. Poutiainen A.M., Koistinen M.J., Airaksinen K.E., et al. Prevalence and natural course of ectopic atrial tachycardia. Eur Heart J 1999, 20:694-700.
4. Granada J., Uribe W., Chyou P.H., et al. Incidence and predictors of atrial flutter in the general population. JAm Coll Cardiol 2000, 36:2242-2246.
5. Fuster V., Rydén L.E., Cannom D.S., American College of Cardiology, American Heart Association Task Force, European Society of Cardiology Committee for Practice Guidelines, European Heart Rhythm Association, Heart Rhythm Society, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006, 8:651-745.
6. Liberthson R.R., Salisbury K.W., Hutter A.M., et al. Atrial tachyarrhythmias in acute myocardial infarction. Am J Med 1976, 60:956-960.
7. Savelieva I., Camm A.J. Atrial fibrillation and heart failure: natural history and pharmacological treatment. Europace 2003, 5:S5-S19.
8. Hunt S.A., Abraham W.T., Chin M.H., American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American College of Chest Physicians, International Society for Heart and Lung Transplantation, Heart Rhythm Society, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:154-235.
9. Kannel W.B., Wolf P.A., Benjamin E.J., et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998, 82:2N-9N.
10. Wyndham C.R., Arnsdorf M.F., Levitsky S. Successful surgical excision of focal paroxysmal atrial tachycardia. Observations invivo and invitro. Circulation 1980, 62:1365-1372.
11. Josephson M.E., Spear J.F., Harken A.H., et al. Surgical excision of automatic atrial tachycardia: anatomic and electrophysiologic correlates. Am Heart J 1982, 104:1076-1085.
12. Gossage A.M., Braxton Hicks J.A. On auricular fibrillation. QJM 1913, 6:435-440.
13. Whipple G.H., Sheffield L.T., Woodman E.G., et al. Reversible congestive heart failure due to rapid stimulation of the normal heart. Proc New Engl Cardiovasc Soc 1961-1962, 20:39-40.
14. Jeong Y.H., Choi K.J., Song J.M., et al. Diagnostic approach and treatment strategy in tachycardia-induced cardiomyopathy. Clin Cardiol 2008, 31:72-78.
15. Medi C., Kalman J.M., Haqqani H., et al. Tachycardia-mediated cardiomyopathy secondary to focal atrial tachycardia: long-term outcome after catheter ablation. JAm Coll Cardiol 2009, 53:1791-1797.
16. Poole J.E., Johnson G.W., Hellkamp A.S., et al. Prognostic importance of defibrillator shocks in patients with heart failure. NEngl J Med 2008, 359:1009-1017.
17. Dorian P., Philippon F., Thibault B., et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004, 1:540-547.
18. Friedman P.A., McClelland R.L., Bamlet W.R., et al. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation 2006, 113:2871-2879.
19. Gasparini M., Galimberti P., Ceriotti C. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy. Curr Opin Cardiol 2013, 28:50-54.
20. Pedersen O.D., Bagger H., Køber L., TRACE Study Group, et al. Impact of congestive heart failure and left ventricular systolic function on the prognostic significance of atrial fibrillation and atrial flutter following acute myocardial infarction. Int J Cardiol 2005, 100:65-71.
21. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. NEngl J Med 1997, 336:525-533.
22. Sarter B.H., Marchlinski F.E. Redefining the role of digoxin in the treatment of atrial fibrillation. Am J Cardiol 1992, 69:71G-81G.
23. Khand A.U., Rankin A.C., Martin W., et al. Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?. JAm Coll Cardiol 2003, 42:1944-1951.
24. Singh S., Fletcher R.D., Fisher S., et al. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Control Clin Trials 1992, 13:339-350.
25. Møller M., Torp-Pedersen C.T., Køber L. Dofetilide in patients with congestive heart failure and leftventricular dysfunction: safety aspects and effect on atrial fibrillation. The Danish Investigators of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Congest Heart Fail 2001, 7:146-150.
26. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. NEngl J Med 1989, 10:406-412.
27. Pratt C.M., Camm A.J., Cooper W., et al. Mortality in the survival with ORal D-sotalol (SWORD) trial: why did patients die?. Am J Cardiol 1998, 81:869-876.
28. Connolly S.J., Camm A.J., Halperin J.L., et al. Dronedarone in high-risk permanent atrial fibrillation. NEngl J Med 2011, 365:268-276.
29. Xia Y., Ju W.Z., Chen M.L., et al. Catheter ablation of focal atrial tachycardia: the topographic distribution and long-term outcome. Zhonghua Xin Xue Guan Bing Za Zhi 2012, 40:231-236. [in Chinese].
30. Pérez F.J., Schubert C.M., Parvez B., et al. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol 2009, 2:393-401.
31. Lee G., Sanders P., Kalman J.M. Catheter ablation of atrial arrhythmias: state of the art. Lancet 2012, 380:1509-1519.
32. Kistler P.M., Roberts-Thomson K.C., Haqqani H.M., et al. P-wave morphology in focal atrial tachycardia: development of an algorithm to predict the anatomic site of origin. JAm Coll Cardiol 2006, 48:1010-1017.
33. Ouyang F., Ma J., Ho S.Y., et al. Focal atrial tachycardia originating from the non-coronary aortic sinus: electrophysiological characteristics and catheter ablation. JAm Coll Cardiol 2006, 48:122-131.
34. Dong J., Schreieck J., Ndrepepa G., et al. Ectopic tachycardia originating from the superior vena cava. JCardiovasc Electrophysiol 2002, 13:620-624.
35. Polymeropoulos K.P., Rodriguez L.M., Timmermans C., et al. Images in cardiovascular medicine. Radiofrequency ablation of a focal atrial tachycardia originating from the Marshall ligament as a trigger for atrial fibrillation. Circulation 2002, 105:2112-2113.
36. Chen S.A., Chiang C.E., Yang C.J., et al. Radiofrequency catheter ablation of sustained intra-atrial reentrant tachycardia in adult patients. Identification of electrophysiological characteristics and endocardial mapping techniques. Circulation 1993, 88:578-587.
37. Natale A., Breeding L., Tomassoni G., et al. Ablation of right and left ectopic atrial tachycardias using a three-dimensional non fluoroscopic mapping system. Am J Cardiol 1998, 82:989-992.
38. Singh B., Sapra R., Gupta R.K., et al. Pace mapping for the localization of focal atrial tachycardia arising near the mitral annulus. Indian Heart J 2004, 56:58-60.
39. Feld G.K., Fleck R.P., Chen P.S., et al. Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 1992, 86:1233-1240.
40. Fischer B., Haissaguerre M., Garrigues S., et al. Radiofrequency catheter ablation of common atrial flutter in 80 patients. JAm Coll Cardiol 1995, 25:1365-1372.
41. Moreira J.M., Alessi S.R., Rezende A.G., et al. Catheter ablation of atrial flutter. Electrophysiological characterization of posterior and septal isthmus block. Arq Bras Cardiol 1998, 71:37-47. [in Portuguese].
42. Jaïs P., Shah D.C., Haïssaguerre M., et al. Mapping and ablation of left atrial flutters. Circulation 2000, 101:2928-2934.
43. Kay G.N., Ellenbogen K.A., Giudici M., et al. Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. JInterv Card Electrophysiol 1998, 2:121-135.
44. Wilkoff B.L., Dual Chamber and VVI Implantable Defibrillator Trial Investigators The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Card Electrophysiol Rev 2003, 7:468-472.
45. Brignole M., Botto G., Mont L., et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 2011, 32:2420-2429.
46. Gehi A.K., Mounsey J.P., Pursell I., et al. Hybrid epicardial-endocardial ablation using a pericardioscopic technique for the treatment of atrial fibrillation. Heart Rhythm 2013, 10:22-28.
47. Li Y.G., Grönefeld G., Israel C., et al. Radiofrequency catheter ablation in patients with symptomatic atrial flutter/tachycardia after orthotopic heart transplantation. Chin Med J (Engl) 2006, 119:2036-2041.
48. Nazmul M., Munger T.M., Powell B.D. Atrial tachycardia originating from a donor pulmonary vein in a lung transplant recipient. Circulation 2011, 124:1288-1289.
49. Lam W., Friedman R.A. Electrophysiology issues in adult congenital heart disease. Methodist Debakey Cardiovasc J 2011, 7:13-17.
50. Akar J.G., Kok L.C., Haines D.E., et al. Coexistance of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. JAm Coll Cardiol 2001, 38:377-384.
51. Maury P., Delmas C., Trouillet C., et al. First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device. JInterv Card Electrophysiol 2010, 29:63-67.
52. Landolina M., Cantù F., De Ferrari G.M., et al. The role of invasive electrophysiology in the management of patients with chronic heart failure. Heart Fail Monit 2002, 3:49-59.